-
公开(公告)号:US20210317480A1
公开(公告)日:2021-10-14
申请号:US17272252
申请日:2019-08-29
Applicant: ShanghaiTech University
Inventor: Jia Liu , Biao Jiang , Peixiang Ma , Guang Yang
Abstract: Provided are amino acid sequences capable of binding to and inhibiting a Cas protein's ability to bind to a nucleic acid molecule, thereby inhibiting the Cas protein's function in genome editing. Such Cas protein inhibitors, which can be comprised of a major coat protein (G8P), an extracellular region of the G8P (G8PEX), or a biological equivalent, are useful in improving the specificity of Cas protein-based genome editing procedures.
-
公开(公告)号:US20220213176A1
公开(公告)日:2022-07-07
申请号:US17702710
申请日:2022-03-23
Applicant: ShanghaiTech University , ShOx Science Limited
Inventor: Peixiang Ma , Guang Yang , Richard A. Lerner , Min Qiang , Hou Wang
Abstract: The present disclosure provides human antibodies and fragments thereof having binding specificity to the SARS-CoV-2 spike protein's receptor binding domain (RBD). The antibodies and fragments have strong affinity and potent neutralization ability against the SARS-CoV-2 virus and various mutant forms. Also provided are trimeric antibodies which have further enhanced neutralization capabilities. The antibodies and fragments thus may be used for preventing or treating SARS-CoV-2 viral infection or detecting the presence of the virus in a sample.
-
公开(公告)号:US11492645B2
公开(公告)日:2022-11-08
申请号:US17272252
申请日:2019-08-29
Applicant: ShanghaiTech University
Inventor: Jia Liu , Biao Jiang , Peixiang Ma , Guang Yang
IPC: C12N15/63 , A61K31/70 , C12N15/90 , A61K31/7088 , A61K38/16 , A61K38/46 , A61K38/50 , C12N7/00 , A01K67/00
Abstract: Provided are amino acid sequences capable of binding to and inhibiting a Cas protein's ability to bind to a nucleic acid molecule, thereby inhibiting the Cas protein's function in genome editing. Such Cas protein inhibitors, which can be comprised of a major coat protein (G8P), an extracellular region of the G8P (G8PEX), or a biological equivalent, are useful in improving the specificity of Cas protein-based genome editing procedures.
-
-